All News

What you missed this week on Contemporary OB/GYN®

Vice President Kamala Harris hosted the White House’s first-ever Maternal Health Day of Action Summit on Dec. 7. During the Summit, Harris outlined the administration’s new initiatives and issued a nationwide call to action for public and private sectors to help improve maternal health outcomes.

A recent analysis suggests transfeminine individuals were at a 40% greater risk of developing diabetes than their cisgender counterparts, but this increase in risk was not attributable to gender-affirming hormone therapy.

Patients in California were able to receive a contraceptive prescription during a visit with a pharmacist.

COVIDmenses is recruiting participants for a study to examine potential effects of COVID-19 vaccination on menstrual health.

Curbside Consults delivers expert perspectives from physicians outside the ob-gyn specialty to provide insight into various health issues affecting pregnant women. In this installment, we learn more about the diagnosis and management of headaches in postpartum patients.

COVID-19 updates and news to know as of December 6, 2021.

A report offers insight into how the Women’s Wellness through Equity and Leadership program performed during its pilot phase.

By July 2021, the FDA had approved or tentatively approved 470 generic versions of medications.

It is essential to expand access to all available, effective cervical cancer screening options for the most vulnerable populations. The targeted use of any particular screening modality in higher-risk populations is not supported by evidence-based guidelines; any effective screening is the priority.

Reliable compensation plans are imperative as health care becomes more complex. Hear from the experts in our new Practice Management column.

Low progesterone levels have been associated with an increased rate of miscarriage.

Here's what's coming up this week on Contemporary OB/GYN.

Wondering what you missed this week?

Contemporary OB/GYN® has aimed to address prevalent topics for our readers, including not only areas related to the pandemic but ones we encounter day to day.

“This vaccine strategy has the potential to be applied to other tumor types,” said Vincent K. Tuohy, PhD, the Mort and Iris November Distinguished Chair in Innovative Breast Cancer Research at Cleveland Clinic Lerner Research Institute, and primary inventor of the vaccine.

In this episode of Pap Talk, we took you with us to the North American Menopause Society's recent Annual Meeting. Sexual health specialist Michael Krychman, MD, sat down with Brooke Faught, NP, to learn more about her work at the Women's Institute for Sexual Health, her role on the NAMS Planning Committee, and her tips for talking trauma with patients.

Patients Desiring Immediate Postpartum Sterilization Should Not Be Required to Wait 30 Days.

Olaparib, which was granted priority review by the FDA, has been shown to improve invasive disease-free survival for patients with BRCA-mutated HER2-negative high-risk early breast cancer.

Retifanlimab demonstrated encouraging antitumor activity with favorable tolerability in patients with recurrent microsatellite instability–high or mismatch repair deficient endometrial cancer, according to data from the phase 1 POD1UM-101 trial.

The US Food and Drug Administration (FDA) is currently investigating whether the new COVID-19 variant will evade current mitigation strategies and diagnostic tools.

An update from infectious disease expert, Rana F. Hamdy, MD, on the Omicron variant of COVID-19.

For girls with additional body weight, using Tanner staging to determine pubertal development may require more care.

Here's what's coming to Contemporary OB/GYN this week.

Racial and ethnic inequities persist in all 50 states.

Attention needs to be paid to the psychosocial needs of patients, especially those with poor health-related quality of life, who have little support, or are single mothers.

From 1976 to 2018, data show the prevalence of obesity in the United States increased from 6.2% to 32.7%.

Surviving a bout of cancer early in life puts children and teenagers at risk of cancers linked to human papillomavirus (HPV). A phase 2 trial examined how effective a 3-dose series was in providing protection.

Top tips and HIPAA implications.

Being informed and educated may help patients with breast cancer make a treatment decision and feel less afraid.